A VISION TO BE THE BEST      

A- A A+

A Vision to be the Best

As the largest group of Retina specialists in the Greater Kansas City, Topeka, Sedalia and surrounding areas we offer multiple professional offices to serve you.  Each of our offices are staffed and equipped to provide the highest level of health care service and access in a comfortable environment.

Blake Anthony Cooper, M.D.

Dr. Cooper CURRICULUM VITAE

NAME

  • Blake Anthony Cooper, M.D., F.A.C.S.

BORN

  • June 1, 1970; Arlington Heights, Illinois

WORK HISTORY

2003 - PRESENT

  • Retina Associates, P.A.
    9301 West 74th Street
    Suite 210
    Shawnee Mission, KS 66204
  • Retina Associates, P.A.
    10100 N Ambassador Drive
    Suite 100
    Kansas City, MO 64153
  • Retina Associates, P.A.
    6001 SW 6th Avenue
    Suite 300
    Topeka, KS 66615
  • Retina Associates, P.A.
    3700 W 10th Street
    Suite 101
    Sedalia, MO 65301
  • Retina Associates, P.A.
    100 NE Missouri Road
    Suite 203
    Lee's Summit, MO 64086

EDUCATION

  • Fellowship Ophthalmology/Retina 2001 - 2003
    Barnes Retina Institute/Washington University Medical Center
    St. Louis, MO
  • Resident in Ophthalmology and Visual Sciences 1999 - 2001
    Barnes-Jewish Hospital/Washington University Medical Center
    St. Louis, MO
  • Transitional Medicine, Louis A. Weiss Memorial Hospital 1997 - 1998
    University of Chicago
    Chicago, IL
  • M.D., Finch University of Health Sciences 1993 - 1997
    The Chicago Medical School
    North Chicago, IL
  • B.A., Biology and Chemistry 1988 - 1992
    Knox College
    Galesburg, IL

CERTIFICATIONS

  • American Board of Ophthlmology

PROFESSIONAL SOCIETIES AND ORGANIZATIONS

  • Alpha Omega Alpha Honor Medical Society
  • American Academy of Ophthalmology
  • American College of Surgeons
  • American Society of Retina Specialists
  • Association for Research in Vision and Ophthalmology
  • St. Louis Ophthalmology Society
  • Kansas Ctiy Ophthalmology Journal Club
  • Kansas Society of Eye Physicians and Surgeons
  • Kansas City Society of Ophthalmology and Otolaryngology
  • Missouri Society of Eye Physicians and Surgeons
  • Missouri State Medical Association
  • Club Vit
  • Midwest Ocular Angiography Conference

PUBLICATIONS

  • Cooper BA, Thomas MA. Surgical management of CNV associated with CSR. Am J Ophthalmol, 2000;130:187-191.
  • Cooper BA, Thomas MA, Holekamp NM. Open retinotomies after subretinal surgery. Am J Ophthalmol; 2000;130:838-839
  • Holekamp NM, Cooper BA. Prophylaxis and treatment of post-surgical cystoid macular edema. Comprehensive Ophthalmology Update, Vol. 1, NO. 4 July – August 2000.
  • Cooper BA, Shah GK. Morning Rounds. Oetting TA (ed). Sometimes a bark is worse than a bite. EyeNet, 2000, 4:3:45-46.
  • Cooper BA, Bohigian G, Holekamp NMs. Endophthalmitis after Cataract Surgery: Scleral Tunnel vs Clear Corneal Wounds A Case – Control Study. Am J Ophthalmol, 2003; 136:300-305.
  • Cooper BA, Shah GK, et al. Outcome of Macular Hole Surgery in Diabetic Patients. Submitted to Ophthalmology. Journal of Retina and Vitreous Diseases;2004;Vol.24;Issue 3:pp 360-362
  • Virata SR, Cooper BA, et al. Retinal Detachments in Fellow Eyes of Patients with Pseudophakic Retinal Detachments, 2004
  • Cooper BA, Grand MG, Shah GK. Photo Essay. Purtscher’s retinopathy associated with SLE. Ophthalmic Surgical Lasers Imaging,2004;Sep-Oct; 35(5);438-439.
  • Rao PK, Almony A, Shah GK, Cooper BA, Smith ME. Histologic and Immunohistochemical Features of a Vitreous Cyst. Retinal Cases & Brief Reports 2004;3:60-61.
  • Cooper BA, Blinder KJ, Shah GK, Foster W, Leibole M. Femtosecond Laser-Induced Premacular Hemorrhage. Retina. 24(5): 812-14, 2004.
  • Cooper BA, Shah GK, Sheidow TG, Blinder KJ, Grand MG. Outcome of Macular Hole Surgery in Diabetic Patients with Nonproliferative Retinopathy. Retina. 24(3):360-2, 2004.
  • Cooper BA, Shah GK, Grand MG, Bakal J, Sharma S. Visual Outcomes and Complications Following Multiple Vitrectomies for Diabetic Vitreous Hemorrhage. Retina. 24(1):19-22, 2004.
  • Cooper BA, Blinder KJ, Shah GK, Boniuk I. Intruding Scleral Sutures Twelve Years After Primary Repair. Archives of Ophthalmology 122:1238, 2004.
  • Shah GK, Cooper BA, Grand MG. Purtscher’s-Like Retinopathy in a Patient with Systemic Lupus Erythematosus. Ophthalmic Surgery, Lasers & Imaging. 35(5)438-9, 2004.
  • Shah GK, Cooper BA, Grand MG, Hart WM. Acute Macular Neuroretinopathy and Associated Disc Swelling and Blind Spot Enlargement – Case Report. Canadian Journal of Ophthalmology. 38(7):602-04, 2003.
  • Holekamp NM and Cooper, BA. Prophylaxis and Treatment of Postsurgical Cystoid Macular Edema Comprehensive Ophthalmology Update 2000;1(4):201-208.
  • Cooper, BA, Thomas MA, and Holekamp NM. Open Retinotomy After Submacular Surgery. Am J Ophthalmol 2000;130:838-839.

LECTURES AND PRESENTATIONS

  • Grand MG, Shah GK, Cooper B, Rosenblatt B. Visual Outcomes After Multiple Vitrectomies. The Retina Debates 2003, Subspecialty Day. November 14-15, 2003.
  • Rao PK, Shah GK, Cooper B, Smith M. Histologic and ultrastructural features of a vitreous cyst. Poster presentation. 21st Annual Meeting American Society of Retina Specialists, Aug. 16-20, 2003.
  • Cooper BA, Shah GK, Rao PK, Smith M. Vitreous Cyst. Verhoeff/Zimmerman Society Meeting. March 2003.
  • Shah GK, Cooper B, Grand MG, Sharma S. Visual Outcomes and Complications Following Multiple Vitrectomies for Diabetic Vitreous Hemorrhage. Poster 03-15. Retina/Vitreous Combined Meeting Sept./Oct. 2002.
  • Cooper BA, Sheidow TG, Grand MG, Sharma S, Shah GK: Outcomes of Macular Hole Surgery in Diabetic Patients. Poster 305. AAO Annual Meeting. November 2001.
  • Virata SR, Shah GK, Cooper BA, Busquets MA, Blinder KJ, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Thomas MA, Sharma S. Retinal Detachments in Fellow Eyes of Patients with Pseudophakic Retinal Detachments. Poster, AAO Annual Meeting, October 24, 2000, Dallas, Texas.
  • Virata SR, Cooper BA, Busquets MA, Blinder KJ, Grand MG, Holekamp NM, Joseph DP, Meredith TA, Thomas MA, Shah GK. Retinal Detachments in Fellow Eyes of Patients with Pseudophakic Retinal Detachments [ARVO Abstract]. Invest Ophthalmol Vis Sci 41(4): S664. Abstract 3528.

RESEARCH

  • Alcon: C-01-99, Investigator, Posterior Juxtascleral Injection of Anecortave Acetate versus Sham for inhibition of CNV in Non-Exudative AMD, 08/2003 – 8/2005.
  • Alcon: C-02-60, Principle Investigator, Anecortave Acetate Risk Reduction Trial for patients with Non-Neovascular AMD, 03/2004 – 08/2008.
  • Alcon: C-04-59, Principle Investigator, Interval Dose Evaluation of Anecortave Acetate for those with Neovascular AMD, 01/2005 – 02/2008.
  • Allergan: 206207-008, Investigator, Posurdex Retinal Vein Occlusion, 01/2005 – 02/2009.
  • Allergan: 206207-010, Investigator, Posurdex Diabetic Macular Edema, 03/2005 – present.
  • DRCR: Intravitreal Triamcinolone study B, Sub-Investigator, Focal laser treatment versus Intravitreal Injection Triamcinolone for treatment of Diabetic Macular Edema, 06/2005 – 10/2006.
  • Eyetech/OSI: EOP1023, Investigator, Intravitreal Injection of Pegaptanib Sodium for Neovascular AMD, 05/2006 – 07/2008.
  • Eyetech IST: Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease (PRESERVE), Sub-Investigator, Intravitreal Injections of Pegaptanib every 4 weeks compared to every 6 weeks for the treatment of Diabetic Macular Edema, 05/2009 - present.
  • Eyetech: EOP1024, Investigator, Intravitreal Injection of Pegaptanib Sodium administered every 6 weeks for 48 weeks for Subfoveal Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, or Retinal Vein Occlusion to determine the adverse effects on the corneal endothelium, 04 – present.
  • Genaera: 301, Investigator, Squalamine Lactate IV infusion for treatment of Neovascular AMD, 09/2005 – 09/2008.
  • Genentech: FVF4165g, Investigator, Intravitreal Injection of Ranibizumab for Branch Retinal Vein Occlusion, 02/2008 – 01/2010.
  • Genentech: FVF4166g, Investigator, Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion, 02/2008 – 01/2010.
  • Genentech: FVF4168g, Principle Investigator, Intravitreal Injection of Ranibizumab for Diabetic Macular Edema, 08/2007 – present.
  • Genentech: FVF4295, Investigator, Evaluation of Ranibizumab on ease of procedure and complications in PDR requiring vitrectomy, 09/2007 – present.
  • Genentech: FVF3426g, Investigator, Intravitreal Injections of Ranibizumab for Branch Retinal Vein Occlusion and Central Retinal Vein Occlusion for subjects who have completed a Genentech Sponsored Ranibizumab Study, 02/2009 – 10/2010.
  • Genentech: FVF4579g, Investigator, Intravitreal Injection of either 0.5mg or 2.0mg Ranibizumab administered monthly or on an as needed basis for subjects with Subfoveal Neovascular Age-Related Macular Degeneration, 06/2009.
  • Eli Lily: B7A-MC-MBCM, Investigator, Ruboxistaurin Mesylate for patients with Diabetic Retinopathy, 01/2003– 04/2006.
  • Eli Lily: B7A-MC-MBDV, Investigator, Open-Label treatment for Patients completing Study B7A-MC-MBCM, 02/2006-11/2008.
  • Ophthotech: OPH3000, Investigator, Intravitreal Injection of Volociximab in combination with Ranibizumab for Neovascular Age-Related Macular Degeneration, 10/2008 – 12/2009.
  • Ophthotech: OPH1001, Investigator, Intravitreal Injection of E10030 (Anti-PDGF Peglayted Aptamer) in combination with Ranibizumab for Neovascular Age-Related Macular Degeneration, 05/2010 – present

A Vision to be the Best

Retina Associates, PA

9301 W 74th St Ste 210
Shawnee Mission, KS 66204

 

Map of our location

Email Us

From (E-mail Address):
Hello, my name is I am interested in scheduling an appointment with your Retina Associates, P.A. and would like to receive information about
Please call me at at your earliest convenience. Thank You!